Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin for Symptomatic Peripheral Neuropathy in Diabetes
NCT00044395Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ruboxistaurin in diabetic peripheral neuropathy (DPN), sponsored by Eli Lilly and Company. Started Jul 2002; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00044395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044395.